Invitae Nabs Bristol Myers Squibb, J&J, Novartis, and Roche for Acute Myeloid Leukemia ProjectThe Motley Fool • 01/14/21
J&J's COVID-19 vaccine candidate shows it generates antibodies in early-stage trialMarket Watch • 01/14/21
J&J's one-shot Covid vaccine is safe and generates promising immune response in early trialCNBC • 01/13/21
J&J Stock Topples On Report Its Covid Vaccine Is 2 Months Behind ScheduleInvestors Business Daily • 01/13/21
Johnson & Johnson's Covid-19 Vaccine Could Alter The Course Of The Pandemic. Investors Will Soon Know If It Works.Barrons • 01/12/21
Retirement Strategy: Johnson & Johnson, Another Buy-And-Hold-Forever Dividend SuperstarSeeking Alpha • 01/12/21
Johnson & Johnson (JNJ) Management Presents at 39th Annual JPMorgan Virtual Healthcare Conference (Transcript)Seeking Alpha • 01/12/21